bioinformatics jobs, bioinformatics career, what is bioinformatics, biotech companies, pharmaceutical companies, etc.

::Bioinformatics Resources::

Home News Companies Tutorials Books Jobs Resources What's Bioinformatics Bioinformatics FAQ

Bioinformatics News 12/2006 (Page 4)

'Good report card' for bioscience effort (The Arizona Republic)
Arizona's bioscience industry is growing in large part from a unique degree of collaboration among bioscience leaders, many of them from the Northeast Valley.

Genome institute to help innovators with start-up funds (New Kerala)
By Lola Nayar, New Delhi, Dec 7: India's premier Institute of Genomics and Integrative Biology (IGIB) is planning to launch a scheme to attract and help innovators in biotech and biogenomics start their own enterprise.

Genome institute to help innovators with start-up funds (Yahoo! India News)
New Delhi, Dec 7 (IANS) India's premier Institute of Genomics and Integrative Biology (IGIB) is planning to launch a scheme to attract and help innovators in biotech and biogenomics start their own enterprise.

PanGenetics B.V. Licenses Therapeutic Antibody for Treatment of Pain from Lay Line Genomics S.p.A. (Business Wire via Yahoo! Finance)
UTRECHT, The Netherlands & CAMBRIDGE, England & ROME, Italy----PanGenetics B.V. and Lay Line Genomics S.p.A. jointly announced today that the companies have entered into a collaboration in the field of therapeutic antibodies for the treatment of pain.

The world's strongest man (Orange County Register)
Augie Nieto is losing muscle to Lou Gehrig's disease. Now, he's tougher than ever.

Tearing Down The Fungal Cell Wall (Science Daily)
Scientists at the Virginia Bioinformatics Institute and Duke University Medical Center have pinpointed a fungal gene that appears to play an important role in the development and virulence of Alternaria brassicicola, a destructive fungal pathogen that results in considerable leaf loss in many economically important crops worldwide, including canola, cabbage and broccoli.

Protein-based Tumor Biomarker Predicts Breast-cancer Survival (Science Daily)
The first and largest clinical trial of its kind confirms that a protein called p27 may be a valuable tool for predicting survival after a diagnosis of breast cancer.

Cedars-Sinai Medical Center Deploys Sun Compute Grid to Uncover New Ways to Treat Diseases (PR Newswire via Yahoo! Finance)
Sun Microsystems , the creator of the Solaris Operating System , announced today that Cedars-Sinai Medical Center is now using a Sun Grid Rack system, comprised of 400 Sun Fire x64 servers, Sun StorageTek solutions, Sun N1 software and pre-integrated by Sun Customer Ready Systems, to process and analyze vast amounts of complex data in the pursuit of medical discoveries that could lead to new

Nanotechnology-Based Products To Accelerate Drug Discovery Developments (DrugDiscoveryOnline)
Research and Markets has announced the addition of "The Role of Nanotechnology in European Drug Discovery" to their offering

Cedars-Sinai Medical Center Deploys Sun Compute Grid to Uncover New Ways to Treat Diseases (FinanzNachrichten)
SANTA CLARA, Calif., Dec. 7 /PRNewswire-FirstCall/ -- Sun Microsystems ( Nachrichten / Aktienkurs ), the creator of the Solaris(TM) Operating System (OS), announced today that Cedars-Sinai Medical Center is now using a Sun(TM) Grid Rack system, comprised of 400 Sun Fire(TM) x64 servers, Sun StorageTek(TM) solutions, Sun N1(TM) software and pre-integrated by Sun Customer Ready Systems, to process

Accelrys To Release SciTegic Pipeline Pilot 6.0, The Scientific Operating Platform For Discovery And Development (DrugDiscoveryOnline)
Accelrys, Inc., a provider of scientific software and services, announced the sixth generation of SciTegic Pipeline Pilot, a platform for scientific discovery and development. Pipeline Pilot 6.0 features major new functionality in the areas of image analysis and bioinformatics, while enterprise enhancements make it easier to define and deploy protocols to a broader audience

Cedars-Sinai Deploys Sun (Byte and Switch)
SANTA CLARA, Calif.

Supercomputing equipment to advance the frontiers of computational biology (EurekAlert!)
Troy, N.Y. -- Researchers at Rensselaer Polytechnic Institute will continue to advance the frontiers of computational science with the help of IBM's Blue Gene supercomputer.

Dr. S.M. Faruque, Scientist and Head, Molecular Genetics Laboratory of LSD, ICDDR,B received TWAS Award in Brazil (News From Bangladesh)
TWAS, the Academy of Sciences for the Developing World, has announced its 2005 prize winners. The annual TWAS Prizes, awarded in eight fields of scientific research, rank among the highest scientific accolades given to scientists in developing countries.

eGene Awarded Taiwanese Patent 'MULTI-CHANNEL BIO-SEPARATION CARTRIDGE' (Business Wire via Yahoo! Finance)
IRVINE, Calif.----eGene Inc. , a leading biotechnology company and developer of a compact and automated digital genetic analyzer, announced today that the Company has received confirmation from the Taiwan Patent Office of its decision to grant a patent for the "Multi-channel bio-separation cartridge."

Biopsy Marker May Predict Breast Cancer's Course (MedicineNet.com)
Title: Biopsy Marker May Predict Breast Cancer's Course Category: Health News Created: 12/7/2006 2:06:00 AM Last Editorial Review: 12/7/2006 2:05:32 AM

Microsoft Builds Relationships in Synthetic Biology (Bio-IT World)
December 07, 2006 | Microsoft Research (MSR) has launched a new funding initiative in the promising but controversial field of computational challenges in synthetic biology.

Supercomputing Equipment To Advance the Frontiers of Computational Biology (Newswise)
Researchers at Rensselaer will continue to advance the frontiers of computational science with the help of IBM's Blue Gene supercomputer. Awarded under IBM's Shared University Research (SUR) program, this Blue Gene will complement the $100 million partnership between Rensselaer, IBM, and New York state to create one of the world's most powerful university-based supercomputing centers.

QuantRx(R) Biomedical Strengthens Financial Position (Market Wire via Yahoo! Finance)
QuantRx® Biomedical Corporation, an emerging leader in the research and development of medical diagnostic platforms and products, today announced the completion of transactions that have strengthened the company's financial position. As a result of its stronger balance sheet, QuantRx will accelerate its growth initiatives and investment in its medical diagnostic intellectual property portfolio.

From A Lowly Yeast, Researchers Divine A Clue To Human Disease (Science Daily)
Working with a common form of brewer's yeast, University of Wisconsin-Madison researchers have uncovered novel functions of a key protein that allow it to act as a master regulatory switch -- a control that determines gene activity and that, when malfunctioning in humans, may contribute to serious neurological disorders.

Sea Urchin Genome Suprisingly Similar To Man And May Hold Key To Cures (Science Daily)
Sea urchins are small and spiny. They have no eyes or ears and yet their genome is very similar to humans' and my hold the key to preventing and curing diseases such as Alzheimer's and Parkinsons.

UA proposes hospital and cancer center for downtown Phoenix (The Arizona Republic)
The University of Arizona College of Medicine and Banner Health are proposing that Banner build a hospital next to the college's downtown Phoenix biomedical campus and a comprehensive cancer center nearby.

Genome institute to help innovators with start-up funds (SiliconIndia)
New Delhi: India's premier Institute of Genomics and Integrative Biology (IGIB) is planning to launch a scheme to attract and help innovators in biotech and biogenomics start their own enterprise.

New clue to cause of Alzheimer's (Newsday)
After decades of going after a sticky substance called beta amyloid that accumulates in the brains of Alzheimer's patients, scientists in Manhattan have discovered a new protein that may play a critical role in the disease process and offer possible treatments.

New bridge to be funded by graduate of Princeton (The Trenton Times)
PRINCETON TOWNSHIP -- A 1964 Princeton University graduate will bankroll most of the cost for the university's planned pedestrian gateway bridge over Washington Road, the university announced yesterday.

Phoenix research group paying its way (Tucson Citizen)
A new study commissioned by TGen shows the downtown Phoenix-based research group last year returned $21.7 million to Arizona's economy and created 220 jobs.

Banner, UA upset hospital debate (The Arizona Republic)
The University of Arizona and Banner Health want to team up to build a hospital on the downtown biomedical campus, a move that would threaten efforts to build a new county hospital in the area.

Acacia Technologies Licenses Multi-Dimensional Bar Code Technology to Capital One (Business Wire via Yahoo! Finance)
NEWPORT BEACH, Calif.----Acacia Research Corporation announced today that VData, LLC, a wholly owned subsidiary that is part of the Acacia Technologies group, a leader in technology licensing, has entered into a license with Capital One covering a portfolio of patents that apply to certain multi-dimensional bar codes.

health briefs (The Olympian)
After decades of going after a sticky substance called beta amyloid that accumulates in the brains of Alzheimer's patients, scientists in Manhattan have discovered a new protein that might play a critical role in the disease process and offer possible treatments.

DNAPrint Pharmaceuticals / Harvard Study Shows PT-401 to Be Three Times More Potent Than Conventional EPOs in Treating (Market Wire via Yahoo! Finance)
DNAPrint Genomics, Inc. today announced the results of preclinical studies conducted by the Company and Harvard Medical School on the Company's proprietary PT-401 protein. The studies demonstrate that PT-401 is three times more effective than conventional EPO treatments, and conclude that PT-401 has "biological activities superior to those of EPO monomer, suggesting important therapeutic

Acacia Technologies Licenses Multi-Dimensional Bar Code Technology to Capital One (Broadcast Newsroom)
NEWPORT BEACH, Calif.,

A Review of Apple's Strategic Weaknesses (The Mac Observer)
The collective Apple community has been so intoxicated by the iPod, the success of the iTunes Store, MacBook sales, and excellent Mac OS X security that no one is reflecting on the areas where Apple is vulnerable. Perhaps it's unpleasant to think about, but neither do we want to live in a state of denial. So here are some areas where I think Apple should pay more attention

Unfolding The Genetic Code: First Molecular Simulation Of A Long DNA Strand Shows Unexpected ... (Science Daily)
Virginia Tech researchers used novel methodology and the university's System X supercomputer to carry out what is probably the first simulation that explores full range of motions of a DNA strand of 147 base pairs, the length that is required to form the fundamental unit of DNA packing in the living cells -- the nucleosome. Contrary to a long-held belief that DNA is hard to bend, the simulation

Chemists Create 'Nanorobotic' Arm To Operate Within DNA Sequence (Science Daily)
New York University chemistry professor Nadrian C. Seeman and his graduate student Baoquan Ding have developed a DNA cassette through which a nanomechanical device can be inserted and function within a DNA array, allowing for the motion of a nanorobotic arm. The results mark the first time scientists have been able to employ a functional nanotechnology device within a DNA array.

CombiMatrix Group to Receive $10 Million from Acacia Research Registered Direct Offering (Business Wire via Yahoo! Finance)
NEWPORT BEACH, Calif.----Acacia Research Corporation announced today that it has obtained commitments to purchase approximately $10 million of its Acacia Research-CombiMatrix common stock and warrants in a registered direct offering.

Genomics Advocate von Eschenbach Confirmed as FDA Commissioner (GenomeWeb News)
GenomeWeb Daily News You are not logged in. Existing subscribers login here . New to GenomeWeb? Register quickly here for your free subscription.

DNAPrint Pharmaceuticals / Harvard Study Shows PT-401 to Be Three Times More Potent Than Conventional EPOs in Treating (RedNova)
DNAPrint Genomics, Inc. (OTCBB: DNAG) today announced the results of preclinical studies conducted by the Company and Harvard Medical School on the Company's proprietary PT-401 protein.

Researchers in Montréal and the US create model of key immune-system component (EurekAlert!)
Montréal, December 8, 2006 -- Researchers at Université de Montréal, working with teams at Massachusetts General Hospital and Johns Hopkins University, have made a major breakthrough in understanding an essential aspect of the immune system.

UAMS Researchers Helping to Unlock a Protein Code With Potential for Treating Disease (PR Newswire via Yahoo! Finance)
Molecular biologists at the University of Arkansas for Medical Sciences recently uncovered some of the first evidence for proteins that can read and write a "protein code," providing a possible pathway to new treatments for diseases such as cancer at the genetic level.

M. Somasekhar (The Hindu)
It's `Europe calling', for Indian pharma and biotech companies, especially from Hyderabad. In just about a year, half a dozen companies have either acquired companies, have forged license agreements or been acquired.

Mapping The Wake Of A Pending Quake: Another Sumatra Tsunami Likely In Coming Decades (Science Daily)
Research into ancient earthquakes by scientists at USC and Caltech shows that within the next few decades another tsunami from another giant earthquake is likely to flood densely populated sections of western coastal Sumatra, south of those that devastated by the tsunami of Dec. 26, 2004.

Aggressive Stem Cells Might Improve Transplant Outcome (Science Daily)
Investigators at St. Jude Children's Research Hospital have demonstrated in mice a way that might reduce the time it takes for a bone marrow transplant to rebuild a child's immune system, and so reduce the risk of potentially fatal virus infections that can occur during this time.

Stocks in the news (Sun-Sentinel)
Increased dividends: Quarterly unless noted otherwise; Acadia Realty Tr .20 from .185; Apollo Invest Cp .50 from .47; Applebees Intl .22A from .20A; Axis Capital Hldg .165 from .15; Bank of Nova Scotia g .42 from .39; Borders Group .11 from .10; Bowl America A .145 from .14; Capital Source Inc .55 from .49; Collector Universe .12 from .08; Communication Sys .10 from 09; DTE Energy .53 from .515;

Regents recognize outstanding service (Eastern Arizona Courier)
Wick Communications co-owner Robert Wick was honored by the Arizona Board of Regents with the 2006 Regents’ Award for Outstanding Service to Higher Education.

Dr. S.M. Faruque, Scientist and Head, Molecular Genetics Laboratory of LSD, ICDDR,B received TWAS Award in Brazil (News From Bangladesh)
TWAS, the Academy of Sciences for the Developing World, has announced its 2005 prize winners. The annual TWAS Prizes, awarded in eight fields of scientific research, rank among the highest scientific accolades given to scientists in developing countries.

Kannada Nudi Kannada Gadi Jagruti Jatha: (Deccan Herald)
Inauguration of convention of representatives from border taluks by poet G S Shivarudrappa 11 am; submission of report to government on the situation in border areas, Chief Minister H D Kumaraswamy, Home Minister M P Prakash, participate, Secretariat Club, Cubbon Park, 4 pm.

MHPCC supercomputer among world’s fastest (The Maui News)
KIHEI – The numbers are like cosmological distances – too big to really comprehend: The new Dell PowerEdge 1955 dedicated Friday at the Maui High Performance Computing Center has a maximum speed of 61 teraflops, memory of more than 353 terabytes.

Antibiotics au naturel (Nature)
Where combinatorial chemistry and genomics have stalled, could an exploration of untapped sources usher in a second golden age of antibiotic discovery? Cormac Sheridan investigates.

Protein pathway may shed light on Alzheimer’s Discovery of protein pathway may shed light on Alzheimer’s (Kansas City Star)
NEW YORK | Scientists have discovered a protein pathway that may play a critical role in Alzheimer’s disease and offer possible treatments.

Banner, UA planning hospital for cancer care (The Arizona Republic)
Banner Health and the University of Arizona's nationally known cancer center announced a partnership Saturday to build a central Phoenix cancer hospital that they say could rival Memorial Sloan-Kettering in New York or M.D. Anderson in Houston.


click here | investments | find local lawyers



Bioinformatics News Archive
Home News Companies Tutorials Books Jobs Resources What's Bioinformatics Bioinformatics FAQ
© Copyright by ColorBasePair.com. All rights reserved.